Safety update: Risdiplam clinical trial program for spinal muscular atrophy (SMA)

被引：1

作者：

Baranello, G. ^{[1
,2
,3
]}

Chiriboga, C. ^{[4
]}

Servais, L. ^{[5
,6
,7
,8
]}

Darras, B. ^{[9
]}

Day, J. ^{[10
]}

Deconinck, N. ^{[11
,12
]}

Farrar, M. ^{[13
,14
]}

Finkel, R. ^{[15
]}

Bertini, E. ^{[16
]}

Kirschner, J. ^{[17
]}

Rasson, M. ^{[3
]}

Mazurkiewicz-Beldzinska, M. ^{[18
]}

Vlodavets, D. ^{[19
]}

Bader-Weder, S. ^{[20
]}

Gorni, K. ^{[21
]}

Jaber, B. ^{[20
]}

Yeung, W. ^{[22
]}

Papp, G. ^{[20
]}

Scalco, R. ^{[23
]}

Mercuri, E. ^{[24
,25
]}

机构：

[1] UCL, NIHR Gt Ormond St Hosp, Dubowitz Neuromusc Ctr, Biomed Res Ctr,Gt Ormond St Inst Child Hlth, London, England

[2] Gt Ormond Str Hosp Trust, London, England

[3] Fdn IRCCS Ist Neurol Carlo Besta, Dev Neurol Unit, Milan, Italy

[4] Columbia Univ, Dept Neurol, Irving Med Ctr, New York, NY USA

[5] Univ Oxford, Dept Paediat, MDUK Oxford Neuromusc Ctr, Oxford, England

[6] Univ Hosp Liege, Div Child Neurol, Dept Paediat, Ctr References Malad Neuromusculaires, Liege, Belgium

[7] Univ Liege, Liege, Belgium

[8] Hop Armand Trousseau, AP HP, I Mot, Inst Myol, Paris, France

[9] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA USA

[10] Stanford Univ, Dept Neurol, Palo Alto, CA USA

[11] Univ Libre Bruxelles, Queen Fabiola Childrens Univ Hosp, Ctr Reference Malad Neuromusculaires, Brussels, Belgium

[12] UZ Gent, Neuromusc Reference Ctr, Ghent, Belgium

[13] Sydney Childrens Hosp Network, Sydney, NSW, Australia

[14] UNSW Sydney, UNSW Med, Sydney, NSW, Australia

[15] St Jude Childrens Res Hosp, Ctr Expt Neurotherapeut, Memphis, TN USA

[16] Bambino Gesu Childrens Res Hosp IRCCS, Res Unit Neuromusc & Neurodegen Disorders, Rome, Italy

[17] Univ Freiburg, Fac Med, Med Ctr, Dept Neuropaediat & Muscle Disorders, Freiburg, Germany

[18] Med Univ Gdansk, Dept Develt Neurol, Gdansk, Poland

[19] Pirogov Russian Nat Res Med Univ, Russian Children Neuromusc Ctr, Veltischev Clin Paed Res Inst, Moscow, Russia

[20] F Hoffmann La Roche Ltd, Pharma Dev Safety, Basel, Switzerland

[21] F Hoffmann La Roche Ltd, PDMA Neurosci & Rare Dis, Basel, Switzerland

[22] Roche Prod Ltd, Welwyn Garden City, Herts, England

[23] F Hoffmann La Roche Ltd, Pharma Dev Neurol, Basel, Switzerland

[24] Catholic Univ, Paediat Neurol Inst, Rome, Italy

[25] Fdn Policlin Gemelli IRCCS, Nemo Pediat, Rome, Italy

来源：

NEUROMUSCULAR DISORDERS | 2023年 / 33卷

关键词：

D O I：

10.1016/j.nmd.2023.07.112

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P230

引用

页码：S92 / S93

页数：2

共 50 条

[1] Safety update: Risdiplam clinical trial development program
Chiriboga, C.
Servais, L.
Baranello, G.
Darras, B.
Day, J.
Deconinck, N.
Farrar, M.
Finkel, R.
Bertini, E.
Kirschner, J.
Masson, R.
Mazurkiewicz-Beldzinska, M.
Vlodavets, D.
Bader-Weder, S.
Gorni, K.
Jaber, B.
McIver, T.
Papp, G.
Scalco, R.
Mercuri, E.
NEUROMUSCULAR DISORDERS, 2022, 32 : S89 - S89
[2] Risdiplam clinical trial outcomes in individuals with spinal muscular atrophy (SMA) and four SMN2 copies
Toy, F.
Bertini, E.
Chiriboga, C. A.
Mercuri, E.
Dickendesher, T.
Li, Y.
Martin, C.
Palfreeman, L.
Tam, S.
Yeung, W.
ANNALS OF NEUROLOGY, 2025, 96 : S126 - S127
[3] RAINBOWFISH: A study of risdiplam in infants with presymptomatic spinal muscular atrophy (SMA)
Servais, L.
Al-Muhaizea, M.
Farrar, M.
Nelson, L.
Prufer, A.
Finkel, R.
Wang, Y.
Zanoteli, E.
El-Khairi, M.
Gerber, M.
Gorni, K.
Kletzl, H.
Palfreeman, L.
Scalco, R.
Bertini, E.
NEUROMUSCULAR DISORDERS, 2021, 31 : S48 - S48
[4] RAINBOWFISH: A Study of Risdiplam in Newborns with Presymptomatic Spinal Muscular Atrophy (SMA)
Finkel, Richard S.
Al-Muhaizea, Mohammad
Farrar, Michelle A.
Nelson, Leslie
Prufer, Alexandra
Servais, Laurent
Wang, Yi
Zanoteli, Edmar
Palfreeman, Laura
El-Khairi, Muna
Gorni, Ksenija
Kletzl, Heidemarie
Gerber, Marianne
Scalco, Renata S.
Bertini, Enrico
NEUROLOGY, 2021, 96 (15)
[5] Risdiplam: A Review in Spinal Muscular Atrophy
Julia Paik
CNS Drugs, 2022, 36 : 401 - 410
[6] Risdiplam for the Use of Spinal Muscular Atrophy
Kakazu, Juyeon
Walker, Nakoma L.
Babin, Katherine Claire
Trettin, Katherine A.
Lee, Christopher
Sutker, Patricia B.
Kaye, Adam M.
Kaye, Alan D.
ORTHOPEDIC REVIEWS, 2021, 13 (02)
[7] RAINBOWFISH: Preliminary efficacy and safety data in risdiplam-treated infants with presymptomatic spinal muscular atrophy (SMA)
Finkel, R.
Farrar, M.
Vlodavets, D.
Zanoteli, E.
Al-Muhaizea, M.
Nelson, L.
Prufer, A.
Servais, L.
Wang, Y.
Fisher, C.
Gerber, M.
Gorni, K.
Kletzl, H.
Palfreeman, L.
Scalco, R.
Bertini, E.
NEUROMUSCULAR DISORDERS, 2022, 32 : S85 - S86
[8] Risdiplam: A Review in Spinal Muscular Atrophy
Paik, Julia
CNS DRUGS, 2022, 36 (04) : 401 - 410
[9] RAINBOWFISH: Primary efficacy and safety data in risdiplam-treated infants with presymptomatic spinal muscular atrophy (SMA)
Finkel, R.
Farrar, M.
Servais, L.
Vlodavets, D.
Zanoteli, E.
Al-Muhaizea, M.
Prufer, A.
Nelson, L.
Fischer, C.
Gerber, M.
Gorni, K.
Kletzl, H.
Palfreeman, L.
Gaki, E.
Fontoura, P.
Bertini, E.
NEUROMUSCULAR DISORDERS, 2023, 33 : S88 - S88
[10] JEWELFISH: Safety and Pharmacodynamic Data in Non-Naive Patients with Spinal Muscular Atrophy (SMA) Receiving Treatment with Risdiplam
Chiriboga, Claudia A.
Bruno, Claudio
Duong, Tina
Fischer, Dirk
Kirschner, Janbernd
Mercuri, Eugenio
Gerber, Marianne
Gorni, Ksenija
Kletzl, Heidemarie
McIver, Tammy
Scalco, Renata S.
Warren, Francis
Scoto, Mariacristina
NEUROLOGY, 2021, 96 (15)

← 1 2 3 4 5 →